Search research articles
Contact Us
Filters
Showing results (1-10 of 55) with videos related to
Page
of 6
Sort By:
Expert Opinion on Drug Safety
|
August 20, 2025
Updates on immunosuppressant safety and malignancy risk in patients with multiple sclerosis
Gloria Dalla Costa, Giancarlo Comi
Expert Review of Neurotherapeutics
|
June 29, 2023
Teriflunomide: an oral therapy for first-line treatment of children and adolescents living with relapsing-remitting multiple sclerosis
Gloria Dalla Costa, Giancarlo Comi
Multiple Sclerosis and Related Disorders
|
September 5, 2022
Emerging trends in multiple sclerosis research
Gloria Dalla Costa, Giancarlo Comi
Expert Opinion on Drug Safety
|
June 14, 2023
A safety review of current monoclonal antibodies used to treat multiple sclerosis
Gloria Dalla Costa, Giancarlo Comi
Expert Review of Neurotherapeutics
|
October 12, 2020
Newly approved agents for relapsing remitting multiple sclerosis: how real-world evidence compares with randomized clinical trials?
Giancarlo Comi, Gloria Dalla Costa, Lucia Moiola
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology
|
May 23, 2013
Refractory migraine: the role of the physician in assessment and treatment of a problematic disease
Bruno Colombo, Dacia Dalla Libera, Gloria Dalla Costa, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology
|
May 31, 2012
From neuroimaging to clinical setting: what have we learned from migraine pain?
Bruno Colombo, Gloria Dalla Costa, Dacia Dalla Libera, et al.
Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia
|
March 27, 2013
Parry Romberg syndrome associated with chronic facial pain
Gloria Dalla Costa, Bruno Colombo, Dacia Dalla Libera, et al.
Clinical Trials (London, England)
|
August 6, 2014
Overcoming recruitment challenges in patients with multiple sclerosis: Results from an Italian survey
Simona Maida, Gloria Dalla Costa, Mariaemma Rodegher, et al.
Expert Review of Clinical Pharmacology
|
October 8, 2024
An overview on disease modifying and symptomatic drug treatments for multiple sclerosis
Gloria Dalla Costa, Letizia Leocani, Mariaemma Rodegher, et al.
Page
of 6
Search research articles
Search
Showing results (1-10 of 55) with videos related to
Sort By:
Page
of 6
Expert Opinion on Drug Safety
|
August 20, 2025
Updates on immunosuppressant safety and malignancy risk in patients with multiple sclerosis
Gloria Dalla Costa, Giancarlo Comi
Expert Review of Neurotherapeutics
|
June 29, 2023
Teriflunomide: an oral therapy for first-line treatment of children and adolescents living with relapsing-remitting multiple sclerosis
Gloria Dalla Costa, Giancarlo Comi
Multiple Sclerosis and Related Disorders
|
September 5, 2022
Emerging trends in multiple sclerosis research
Gloria Dalla Costa, Giancarlo Comi
Expert Opinion on Drug Safety
|
June 14, 2023
A safety review of current monoclonal antibodies used to treat multiple sclerosis
Gloria Dalla Costa, Giancarlo Comi
Expert Review of Neurotherapeutics
|
October 12, 2020
Newly approved agents for relapsing remitting multiple sclerosis: how real-world evidence compares with randomized clinical trials?
Giancarlo Comi, Gloria Dalla Costa, Lucia Moiola
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology
|
May 23, 2013
Refractory migraine: the role of the physician in assessment and treatment of a problematic disease
Bruno Colombo, Dacia Dalla Libera, Gloria Dalla Costa, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology
|
May 31, 2012
From neuroimaging to clinical setting: what have we learned from migraine pain?
Bruno Colombo, Gloria Dalla Costa, Dacia Dalla Libera, et al.
Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia
|
March 27, 2013
Parry Romberg syndrome associated with chronic facial pain
Gloria Dalla Costa, Bruno Colombo, Dacia Dalla Libera, et al.
Clinical Trials (London, England)
|
August 6, 2014
Overcoming recruitment challenges in patients with multiple sclerosis: Results from an Italian survey
Simona Maida, Gloria Dalla Costa, Mariaemma Rodegher, et al.
Expert Review of Clinical Pharmacology
|
October 8, 2024
An overview on disease modifying and symptomatic drug treatments for multiple sclerosis
Gloria Dalla Costa, Letizia Leocani, Mariaemma Rodegher, et al.
Page
of 6